InjectionInjection
Schedule H (Prescription Required)AntimalarialsCode: 304

α-β Arteether Injection 150 mg

Generic Formulation:α-β Arteether Injection 150 mg
Pack Size:2 ml Ampoule
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹17.81
Brand Estimate*
₹77.68
Estimated Savings:₹59.87 (77% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

alpha-beta Arteether is an ethyl ether derivative of artemisinin formulated in an oily injectable vehicle. It exerts potent, rapid schizontocidal activity against erythrocytic stages of Plasmodium falciparum and Plasmodium vivax via endoperoxide radical-mediated damage to parasite membranes. Indicated for severe falciparum malaria, cerebral malaria, and chloroquine-resistant malaria.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 304.Report inaccuracy

Usage Guidelines

Administered strictly by deep intramuscular (IM) injection in the gluteal region by trained clinical personnel. Not for intravenous use. Injections are typically given on 3 consecutive days.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Pain and induration at injection site, dizziness, nausea, fever, headache. Rare/Severe: Prolongation of QT interval, neurotoxicity at excessive doses, and transient reticulocytopenia.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Contraindicated in first-trimester pregnancy unless life-saving alternatives are unavailable. Not for IV administration. Complete the prescribed course and ensure follow-up blood smears to verify parasite clearance.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.